Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Assets Average (2016 - 2025)

Historic Assets Average for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to $160.4 million.

  • Assembly Biosciences' Assets Average rose 4879.37% to $160.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.4 million, marking a year-over-year increase of 4879.37%. This contributed to the annual value of $128.0 million for FY2024, which is 728.11% up from last year.
  • Assembly Biosciences' Assets Average amounted to $160.4 million in Q3 2025, which was up 4879.37% from $89.9 million recorded in Q2 2025.
  • Assembly Biosciences' Assets Average's 5-year high stood at $281.1 million during Q1 2021, with a 5-year trough of $59.1 million in Q3 2023.
  • Its 5-year average for Assets Average is $144.5 million, with a median of $117.6 million in 2024.
  • Its Assets Average has fluctuated over the past 5 years, first plummeted by 5538.77% in 2023, then surged by 8238.08% in 2024.
  • Over the past 5 years, Assembly Biosciences' Assets Average (Quarter) stood at $220.0 million in 2021, then crashed by 49.25% to $111.7 million in 2022, then decreased by 15.61% to $94.2 million in 2023, then rose by 16.44% to $109.7 million in 2024, then surged by 46.19% to $160.4 million in 2025.
  • Its Assets Average stands at $160.4 million for Q3 2025, versus $89.9 million for Q2 2025 and $109.1 million for Q1 2025.